Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Monash IVF Group Ltd ( (AU:MVF) ) just unveiled an announcement.
Monash IVF Group Ltd announced the cessation of 2,564,204 performance rights due to the lapse of conditional rights, as the conditions were not met or became incapable of being satisfied. This development may impact the company’s capital structure and could have implications for stakeholders, particularly in terms of employee incentives and shareholder value.
The most recent analyst rating on (AU:MVF) stock is a Hold with a A$0.77 price target. To see the full list of analyst forecasts on Monash IVF Group Ltd stock, see the AU:MVF Stock Forecast page.
More about Monash IVF Group Ltd
Monash IVF Group Ltd operates in the healthcare industry, primarily focusing on fertility services and reproductive health. The company provides a range of services including in-vitro fertilization (IVF) and other assisted reproductive technologies, catering to individuals and couples seeking fertility solutions.
Average Trading Volume: 4,754,459
Technical Sentiment Signal: Sell
Current Market Cap: A$270.8M
For detailed information about MVF stock, go to TipRanks’ Stock Analysis page.